Author Correction: Pharmacokinetics, mass balance, and metabolism of [14C]vicagrel, a novel irreversible P2Y12 inhibitor in humans
Yuan-dong Zheng1,2,
Hua Zhang3,4,
Yan Zhan1,2,
Yi-cong Bian3,4,
Sheng Ma3,4,
Hai-xian Gan1,
Xiao-juan Lai5,
Yong-qiang Liu5,
Yan-chun Gong5,
Xue-fang Liu5,
Hong-bin Sun6,
Yong-guo Li7,
Da-fang Zhong1,2,
Li-yan Miao3,4,
Xing-xing Diao1,2
1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China
2 University of Chinese Academy of Sciences, Beijing 100049, China
3 Department of Clinical Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou 215123, China
4 Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou 215006, China
5 Jiangsu Vcare PharmaTech Co. Ltd., Nanjing 211800, China
6 State Key Laboratory of Natural Medicines and Center of Drug Discovery, College of Pharmacy, China Pharmaceutical University, Nanjing 210009, China
7 Guangzhou JOYO Pharma Ltd., Shanghai 201203, China
Correspondence to: Da-fang Zhong: dfzhong@simm.ac.cn, Li-yan Miao: miaolysuzhou@163.com, Xing-xing Diao: xxdiao@simm.ac.cn,
DOI: 10.1038/s41401-023-01130-6
1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China
2 University of Chinese Academy of Sciences, Beijing 100049, China
3 Department of Clinical Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou 215123, China
4 Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou 215006, China
5 Jiangsu Vcare PharmaTech Co. Ltd., Nanjing 211800, China
6 State Key Laboratory of Natural Medicines and Center of Drug Discovery, College of Pharmacy, China Pharmaceutical University, Nanjing 210009, China
7 Guangzhou JOYO Pharma Ltd., Shanghai 201203, China
Correspondence to: Da-fang Zhong: dfzhong@simm.ac.cn, Li-yan Miao: miaolysuzhou@163.com, Xing-xing Diao: xxdiao@simm.ac.cn,
DOI: 10.1038/s41401-023-01130-6
Advance online: 2 August 2023